Return Peptide Library
DA-1726
CLevel 1 evidenceDA-1726
GLP-1 and incretin receptor agonists
Basic Information
Categories
GLP-1R/GCGR dual receptor agonist
Overview
MetaVia Therapeutics' once-weekly oxyntomodulin analog dual GLP-1R/GCGR agonist.
Efficacy Rating
Research, Weight Loss, GLP-1
Evidence Level
Class C
Evidence Type
No data available
Confidence
No data available
China Regulatory Status
Cosmetic Ingredient Directory
No data available
Food/Supplements
No data available
Medicine
No data available
Similar Peptide Recommendations
ASC30
ASC30
CGLP-1 and incretin receptor agonists
Research, GLP-1, small molecules
Avexitide
Avexitide
CGLP-1 and incretin receptor agonists
Research, GLP-1 antagonists, hypoglycemia
Berobenatide
Berobenatide
CGLP-1 and incretin receptor agonists
GLP-1, Weight Loss, Obesity
Imapextide
Imapextide
CGLP-1 and incretin receptor agonists
Research: GLP-1 Antagonists and Post-Bariatric Hypoglycemia
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.